https://www.selleckchem.com/pr....oducts/brr2-inhibito
Patients with CSW had poorer outcomes in regard to ISS (21.8 vs 14.2, p less then 0.0001), HLOS (14.1 vs 3.5, p less then 0.0001), ventilator days (5.0 vs 0.45, p less then 0.0001), ICU LOS (8.5 vs 1.6, p less then 0.0001), and survival to discharge (88% vs 99%, p less then 0.0001). Discussion Common adverse effects of CSW were noted in this study. Patients with TBI have a predilection towards development of CSW and consequently have poorer outcomes including increased morbidity and mortality. Data is sparse on the duration of
Like
Comment
Share
